MEDFAR Clinical Solutions Funding: $55M Raised, Series C
MEDFAR Clinical Solutions is based in Montreal, Canada. It has raised $55M in total funding. Latest round: Series C. Backed by Investissement Quebec.
MEDFAR Clinical Solutions funding overview
MEDFAR Clinical Solutions is based in Montreal, Canada. MEDFAR Clinical Solutions has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2023. The round record for MEDFAR Clinical Solutions runs through 2023; nothing later has been disclosed. Investors on record include Investissement Quebec.
MEDFAR Clinical Solutions at a glance
Total raised
$55M
Latest round
Series C
Latest round date
April 2023
Headquarters
Montreal, Canada
Notable investors
Investissement Quebec
Frequently asked about MEDFAR Clinical Solutions funding
How much has MEDFAR Clinical Solutions raised?
MEDFAR Clinical Solutions has raised $55M in total disclosed funding across the rounds on record.
Who has invested in MEDFAR Clinical Solutions?
Investissement Quebec are named among the investors backing MEDFAR Clinical Solutions.
What was the latest MEDFAR Clinical Solutions funding round?
The most recent disclosed round is a Series C, announced in April 2023.
Where is MEDFAR Clinical Solutions based?
MEDFAR Clinical Solutions is based in Montreal, Canada.
When did MEDFAR Clinical Solutions last raise?
The last disclosed MEDFAR Clinical Solutions round closed in April 2023 at Series C.
MEDFAR Clinical Solutions totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Montreal below to benchmark round size and investor mix.
Companies related to MEDFAR Clinical Solutions (19)
